Associate Professor in Pediatrics, Northwestern University Medical School

Pediatric Hematology & Oncology

Dr. Nobuko Hijiya, MD

Nobuko Hijiya is an expert in the field of Pediatric Hematology & Oncology. She studied medicine at NYU School of Medicine. Nobuko Hijiya is a published doctor as well. She has 33 publications published. The latest was: [Clinical effect of prostaglandin E1 on liver dysfunction due to high-dose methotrexate].

Publications

Asparaginase-associated toxicity in children with Acute lymphoblastic leukemia.
Pediatric chronic myeloid Leukemia is a unique disease that requires a different approach.
Targeting novel signaling pathways for resistant Acute myeloid leukemia.
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem Cell rescue for high-risk neuroblastoma.
Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
Female Reproductive Health After Childhood, Adolescent, and Young Adult Cancers: Guidelines for the Assessment and Management of Female Reproductive Complications.
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed Acute lymphoblastic leukemia.
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed Acute leukemia.
Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric Acute lymphoblastic leukemia.
Effective treatment of advanced-stage childhood lymphoblastic Lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with Acute lymphoblastic leukemia in first relapse.
Patient-reported outcomes in end-of-life research in pediatric oncology.
Ancestry and pharmacogenetics of antileukemic drug toxicity.
Cumulative incidence of secondary neoplasms as a first event after childhood Acute lymphoblastic leukemia.
Body mass index does not influence pharmacokinetics or outcome of treatment in children with Acute lymphoblastic leukemia.
Prognostic significance of CD20 expression in childhood B-cell precursor Acute lymphoblastic leukemia.
Successive clinical trials for childhood Acute myeloid leukemia at St Jude Children''s Research Hospital, from 1980 to 2000.
Risk of adverse events after completion of therapy for childhood Acute lymphoblastic leukemia.
Overt testicular disease at diagnosis of childhood Acute lymphoblastic leukemia: lack of therapeutic role of local irradiation.
Myositis complicating viridans streptococcal sepsis in childhood Leukemia.
Lack of benefit of early detection of relapse after completion of therapy for Acute lymphoblastic leukemia.
Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood Acute myelomonocytic or monocyt...
Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric Cancer treatment protocols.
Low-dose oral etoposide-based induction regimen for children with Acute lymphoblastic leukemia in first bone marrow relapse.
Clinical significance of minimal residual disease in childhood Acute lymphoblastic leukemia after first relapse.
Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides.
Dose-dependent kinetics of orally administered 6-mercaptopurine in children with Leukemia.
[Pharmacokinetics of 6-mercaptopurine in children with Acute lymphoblastic leukemia--interindividual and intraindividual variations].
Malignant mediastinal germ-Cell tumors in childhood: a report of two cases achieving long-term disease-free survival.
[Clinical effect of prostaglandin E1 on Liver dysfunction due to high-dose methotrexate].
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.

Schools

Nigata University School Of Medicine
Bellevue Hospital Center
Mem Sloan Kettering Cancer Center
Nyu Hospitals Center

Conditions Treated

Acute Leukemia
Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
Brain Cancer
Liver Cancer
View All

Doctors Specialties

Pediatric Hematology
Oncology

Accepted Insurances

Education

NYU School of Medicine
Memorial Sloan-Kettering Cancer Center

Hospital

Ann & Robert H. Lurie Children?
Lurie Children's Hospital of Chicago

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. John F. Shern, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven C. Aller, MD This Doctor is OpenDoctor Recommended.
	Dr. Nisha C. Kakodkar, MD This Doctor is OpenDoctor Recommended.
	Dr. Samuel L. Volchenboum, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer Reichek, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer Schneiderman, MD This Doctor is OpenDoctor Recommended.
	Dr. Reggie E. Duerst, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Rudy J. Allen, MD This Doctor is OpenDoctor Recommended.